Detalles de la búsqueda
1.
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 83(4): 475-487, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129117
2.
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial.
Rheumatology (Oxford)
; 63(3): 698-705, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399108
3.
Discovery of a potent and selective CBP bromodomain inhibitor (Y08262) for treating acute myeloid leukemia.
Bioorg Chem
; 142: 106950, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924753
4.
Structural insights revealed by the cocrystal structure of CCS1477 in complex with CBP bromodomain.
Biochem Biophys Res Commun
; 623: 17-22, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35868068
5.
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
Clin Exp Rheumatol
; 38(4): 732-741, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452344
6.
CBP/p300 Degrader: A Promising Therapeutic Strategy for Treatment of Prostate Cancer and Beyond.
J Med Chem
; 67(7): 5272-5274, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517344
7.
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
BioDrugs
; 38(1): 145-156, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737952
8.
Discovery of a Promising CBP/p300 Degrader XYD129 for the Treatment of Acute Myeloid Leukemia.
J Med Chem
; 67(11): 9194-9213, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38829718
9.
Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity.
J Med Chem
; 67(9): 6952-6986, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649304
10.
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study.
Lancet Reg Health West Pac
; 42: 100925, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357391
11.
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study.
RMD Open
; 9(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720560
12.
Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.
Rheumatol Ther
; 10(3): 757-773, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36964872
13.
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study.
Arthritis Res Ther
; 24(1): 136, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689239
14.
Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
Eur J Med Chem
; 236: 114311, 2022 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385803
15.
Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer.
J Med Chem
; 65(1): 785-810, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962793
16.
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study.
Ther Adv Musculoskelet Dis
; 13: 1759720X211006964, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959198
17.
Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE.
Adv Ther
; 38(1): 772-781, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33237533
18.
Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE.
Rheumatol Ther
; 7(4): 851-866, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876903
19.
Preparation of Janus-type catalysts and their catalytic performance at emulsion interface.
J Colloid Interface Sci
; 490: 357-364, 2017 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914334
Resultados
1 -
19
de 19
1
Próxima >
>>